The present invention provides an epigallocatechin gallate derivative (EGCG derivative) that has excellent safety and antibacterial properties. An epigallocatechin gallate derivative represented by the following chemical formula (1), an isomer thereof, or a salt thereof is used as an antibacterial a
The present invention provides an epigallocatechin gallate derivative (EGCG derivative) that has excellent safety and antibacterial properties. An epigallocatechin gallate derivative represented by the following chemical formula (1), an isomer thereof, or a salt thereof is used as an antibacterial agent. In the formula, R1 to R6 are each a hydrogen atom, halogen, sodium, potassium, or a straight-chain or branched, saturated or unsaturated acyl group and may be identical to or different from one another. The acyl group may be substituted further with one or more substituents. At least one of the R1 to R6 is the acyl group. R7 to R16 are each a hydrogen atom, halogen, sodium, or potassium and may be identical to or different from one another.
대표청구항▼
1. A method for inhibiting bacterial infection by S. aureus, the method comprising: administering an epigallocatechin gallate derivative represented by the following chemical formula (1), an isomer thereof, or a salt thereof, wherein the isomer is a tautomer, a stereoisomer or an optical isomer: whe
1. A method for inhibiting bacterial infection by S. aureus, the method comprising: administering an epigallocatechin gallate derivative represented by the following chemical formula (1), an isomer thereof, or a salt thereof, wherein the isomer is a tautomer, a stereoisomer or an optical isomer: where:R1 to R6 are each a hydrogen atom, halogen, sodium, potassium, or an acyl group and may be identical to or different from one another,wherein the acyl group has the following chemical formula (2): —C(O)R17 (2),where R17 is a straight or branched, saturated or unsaturated hydrocarbon chain that includes a carbon number of 1 to 19, and may be substituted with one or more substituents, wherein the one or more substituents are independently selected from the group consisting of an alkyl group, amino group, an alkylamino group or a dialkylamino group,whereinat least one of R1 to R6 is the acyl group, where R17 of the acyl group of the at least one of R1 to R6 is an unsaturated hydrocarbon chain;R12 and R14 are a hydrogen atom, halogen, sodium, or potassium and may be identical to or different from one another; andR7 to R11, R13, R15, and R16 are each a hydrogen atom. 2. The method according to claim 1, wherein the alkyl group is a straight-chain or branched alkyl group having 1 to 6 carbon atoms,an alkyl group in the alkylamino group is a straight-chain or branched alkyl group having 1 to 6 carbon atoms,an alkyl group in the dialkylamino group is a straight-chain or branched alkyl group having 1 to 6 carbon atoms, andR1 to R6 may be identical to or different from one another. 3. The method according to claim 1, wherein the alkyl group is a methyl group,the alkylamino group is a methylamino group,the dialkylamino group is a dimethylamino group, andR1 to R6 may be identical to or different from one another. 4. The method according to claim 1, wherein at least one of R1, R2, R5, and R6 is the acyl group. 5. The method according to claim 1, wherein at least one of R1, R2, R5, and R6 is the acyl group, and the rest are each a hydrogen atom. 6. The method according to claim 1, wherein R12 and R14 are a hydrogen atom. 7. The method according to claim 1, wherein the number of carbon atoms in R17 in the acyl group is 12 to 18. 8. The method according to claim 1, wherein R17 in the acyl group is at least one of a saturated straight hydrocarbon-chain and an unsaturated straight hydrocarbon-chain. 9. The method according to claim 1, wherein the acyl group is at least one acyl group selected from the group consisting of a butyryl group, an octanoyl group, a trans-8-methyl-6-nonenoyl group, a geranoyl group, a lauroyl group, 12-(dimethylamino)lauroyl group, a farnesoyl group, a palmitoyl group, a palmitoleyl group, a stearoyl group, an oleoyl group, a linoleyl group, a linolenyl group, an eicosanoyl group, and isomers thereof, wherein the isomers are tautomers, stereoisomers or optical isomers.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (1)
Shimamura Tadakatsu (4-4 ; Nishihara-1-chome Shibuya-ku Tokyo JPX) Hara Yukihiko (Fujieda JPX), Method for inhibiting and treating infection caused by influenza virus.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.